Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Quest Diagnostics ( (DGX) ).
On May 6, 2026, Quest Diagnostics issued $500 million of 5.000% senior unsecured notes due June 30, 2036, with interest payable semiannually beginning December 30, 2026. The notes, which rank equally with the company’s other senior unsecured obligations and have no sinking fund, add long-term fixed-rate debt to the company’s capital structure.
The notes were issued under an existing indenture with The Bank of New York Mellon as trustee, supplemented on May 6, 2026, and include covenants restricting certain liens, sale-leaseback transactions, and major corporate restructurings. In the event of a defined change-of-control triggering event, Quest must offer to repurchase the notes at 101% of principal plus accrued interest, providing additional protection for noteholders.
The most recent analyst rating on (DGX) stock is a Hold with a $220.00 price target. To see the full list of analyst forecasts on Quest Diagnostics stock, see the DGX Stock Forecast page.
Spark’s Take on DGX Stock
According to Spark, TipRanks’ AI Analyst, DGX is a Outperform.
Overall score is supported primarily by a strong and guidance-raising earnings outlook with robust volume/organic growth and expected margin expansion. This is balanced by only mid-level underlying financial statement strength (notable leverage and softer recent cash conversion) and mixed near-term technical momentum, while valuation looks reasonable rather than deeply compelling.
To see Spark’s full report on DGX stock, click here.
More about Quest Diagnostics
Quest Diagnostics Incorporated operates in the healthcare diagnostics industry, providing laboratory testing services and related diagnostic information to physicians, hospitals, employers and health plans. The company focuses on clinical testing and data services that support medical decision-making and patient care across the U.S. healthcare system.
Average Trading Volume: 977,865
Technical Sentiment Signal: Buy
Current Market Cap: $21.13B
Find detailed analytics on DGX stock on TipRanks’ Stock Analysis page.